Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s disease
✍ Scribed by Dario Sorrentino; Claudio Avellini; Carlo Alberto Beltrami; Enrico Pasqual; Ester Zearo
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 469 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Background: This is the first report on a case of Crohn's disease (CD), who was successfully maintained with a combination of infliximab (IFX) and selective depletion of granulocytes/monocytes by adsorption (GMA). Case: A 33‐year‐old female with CD activity index (CDAI) 294.2 responded
## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132